NFKB1 and glioblastoma: Celecoxib additionally enhanced the effects of glucocorticoids triggering apoptosis in GBM cells by suppressing cyclooxygenase-2 (COX-2), which resulted in Akt-mediated activation of NF-κB and subsequent apoptosis [63,64].